Gao Y, Qiao X, Liu Z, Zhang W
Front Immunol. 2024; 15:1397303.
PMID: 38807594
PMC: 11130366.
DOI: 10.3389/fimmu.2024.1397303.
Cvekl A, Camerino M
Cells. 2022; 11(21).
PMID: 36359912
PMC: 9658148.
DOI: 10.3390/cells11213516.
Rozanska A, Cerna-Chavez R, Queen R, Collin J, Zerti D, Dorgau B
Stem Cells Transl Med. 2022; 11(4):415-433.
PMID: 35325233
PMC: 9052432.
DOI: 10.1093/stcltm/szac008.
Rennhack J, Andrechek E
Sci Rep. 2020; 10(1):17948.
PMID: 33087787
PMC: 7578094.
DOI: 10.1038/s41598-020-74877-1.
Jusino S, Saavedra H
Exp Biol Med (Maywood). 2019; 244(16):1419-1429.
PMID: 31575294
PMC: 6900705.
DOI: 10.1177/1535370219881360.
Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.
Aubrecht T, Faden A, Sabirzhanov B, Glaser E, Roelofs B, Polster B
Cell Death Dis. 2018; 9(11):1121.
PMID: 30401820
PMC: 6219504.
DOI: 10.1038/s41419-018-1156-y.
Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.
Liban T, Medina E, Tripathi S, Sengupta S, Henry R, Buchler N
Proc Natl Acad Sci U S A. 2017; 114(19):4942-4947.
PMID: 28439018
PMC: 5441720.
DOI: 10.1073/pnas.1619170114.
Transgenic Models in Retinoblastoma Research.
Nair R, Vemuganti G
Ocul Oncol Pathol. 2016; 1(3):207-13.
PMID: 27171579
PMC: 4847202.
DOI: 10.1159/000370157.
Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice.
Chinnam M, Wang X, Zhang X, Goodrich D
Mol Cell Biol. 2016; 36(11):1621-7.
PMID: 27001308
PMC: 4959316.
DOI: 10.1128/MCB.01003-15.
Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.
Kundrotas G, Gasperskaja E, Slapsyte G, Gudleviciene Z, Krasko J, Stumbryte A
Oncotarget. 2016; 7(10):10788-802.
PMID: 26910916
PMC: 4905439.
DOI: 10.18632/oncotarget.7456.
Loss of E2F1 Extends Survival and Accelerates Oral Tumor Growth in HPV-Positive Mice.
Zhong R, Bechill J, Spiotto M
Cancers (Basel). 2015; 7(4):2372-85.
PMID: 26670255
PMC: 4695895.
DOI: 10.3390/cancers7040895.
Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis.
Lee M, Oprea-Ilies G, Saavedra H
Oncotarget. 2015; 6(35):37316-34.
PMID: 26512919
PMC: 4741932.
DOI: 10.18632/oncotarget.5686.
Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis.
Rajabi H, Takahashi C, Ewen M
J Biol Chem. 2014; 289(34):23417-27.
PMID: 25006242
PMC: 4156083.
DOI: 10.1074/jbc.M113.532572.
Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation.
Ghazaryan S, Sy C, Hu T, An X, Mohandas N, Fu H
Mol Cell Biol. 2014; 34(15):2833-47.
PMID: 24865965
PMC: 4135565.
DOI: 10.1128/MCB.01651-13.
Animal models in retinoblastoma research.
Nair R, Kaliki S, Vemuganti G
Saudi J Ophthalmol. 2013; 27(3):141-6.
PMID: 24227978
PMC: 3770224.
DOI: 10.1016/j.sjopt.2013.06.008.
Contrasting roles of E2F2 and E2F3 in cardiac neovascularization.
Zhou J, Wu M, Xu S, Cheng M, Ding C, Liu Y
PLoS One. 2013; 8(6):e65755.
PMID: 23799044
PMC: 3683051.
DOI: 10.1371/journal.pone.0065755.
Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.
Zhou J, Cheng M, Wu M, Boriboun C, Jujo K, Xu S
J Mol Cell Cardiol. 2013; 60:68-71.
PMID: 23603666
PMC: 3684263.
DOI: 10.1016/j.yjmcc.2013.04.009.
E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.
Chen D, Chen Y, Forrest D, Bremner R
Cell Death Differ. 2013; 20(7):931-40.
PMID: 23558950
PMC: 3679457.
DOI: 10.1038/cdd.2013.24.
Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation.
Landman A, Danielian P, Lees J
Oncogene. 2012; 32(40):4798-805.
PMID: 23146901
PMC: 3931423.
DOI: 10.1038/onc.2012.496.
E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
Carvajal L, Hamard P, Tonnessen C, Manfredi J
Genes Dev. 2012; 26(14):1533-45.
PMID: 22802528
PMC: 3404382.
DOI: 10.1101/gad.184911.111.